PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE MUTATION

This adverse event was reported 6 times

These drugs are most commonly taken by patients reporting PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE MUTATION:

# Drug Count
0 DOXORUBICIN 3
1 GILTERITINIB 3
2 PREDNISONE 3
3 RITUXIMAB 3
4 CYCLOPHOSPHAMIDE 2
5 CYCLOPHOSPHAMIDE FOR INJECTION 2
6 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 2
7 CYTARABINE 2
8 ETOPOSIDE 2
9 MITOXANTRONE HYDROCHLORIDE 2
See all common drugs associated with PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE MUTATION

PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE MUTATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GILTERITINIB 3 0.0007
1 MITOXANTRONE HYDROCHLORIDE 2 0.0003
2 LUBIPROSTONE 1 0.0001
3 VINCRISTINE SULFATE 2 0.0001
4 TAMSULOSIN HYDROCHLORIDE 1 0.0000
5 DEFERASIROX 1 0.0000
6 DOXORUBICIN 3 0.0000
7 AZACITIDINE 1 0.0000
8 SENNOSIDES 1 0.0000
9 CYTARABINE 2 0.0000
See all drugs enriched for association with PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE MUTATION

PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE MUTATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Chloride Channel Activator [EPC] 1 0.0001
1 Iron Chelator [EPC] 1 0.0000
2 Topoisomerase Inhibitor [EPC] 2 0.0000
3 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
4 Alkylating Drug [EPC] 2 0.0000
5 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
6 Corticosteroid [EPC] 3 0.0000
7 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
8 Atypical Antipsychotic [EPC] 1 0.0000
See all drug classes enriched for association with PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE MUTATION